Simon Rothen is CEO of sitem-insel AG.
He studied biotechnology at ETH Zurich and received his doctorate in bioprocess engineering.
His professional career began at Berna Biotech, where he most recently held the position of Chief Operations Officer (COO). Simon Rothen also remained loyal to the life science industry when, after 10 years, he moved to Medisupport, the Swiss network of medical laboratories. There he was member of the executive board of Medisupport and, for the first for five years CEO of MCL Medizinische Laboratorien AG. Subsequently until 2017 he led Genesupport SA, which aims to implement genomic sciences in medical diagnostics.
In 2017 Simon Rothen took over the management of Mouvent AG, a newly founded joint venture between the Bobst Group and other smaller companies. Mouvent is active in the field of industrial digital printing technology.
He is married, has two adult sons and lives with his family in Thörishaus.